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ABSTRACT
Objective: Primary progressive aphasia (PPA) has been proposed to comprise 3 discrete clinical
subtypes: semantic, agrammatic/nonfluent, and logopenic. Recent consensus recommendations
suggest a diagnostic framework based primarily on clinical and neuropsychological findings to
classify these variants. Our objective was to evaluate the extent to which patients with PPA would
conform to the proposed tripartite system and whether the clustering pattern of elements of the
linguistic profile suggests discrete clinical syndromes.
Methods: A total of 46 patients with PPA were prospectively recruited to the Cambridge Longitu-
dinal Study of PPA. Sufficient data were collected to assess all consensus-proposed diagnostic
domains. By comparing patients’ performances against those of 30 age- and education-matched
healthy volunteers, z scores were calculated, and values of 1.5 SDs outside control participants’
means were considered abnormal. Raw test scores were used to undertake a principal factor
analysis to identify the clustering pattern of individual measures.
Results: Of the patients, 28.3%, 26.1%, and 4.3% fitted semantic, nonfluent/agrammatic, and
logopenic categories respectively, and 41.3% did not fulfill the diagnostic recommendations for
any of the 3 proposed variants. There was no significant between-group difference in age, educa-
tion, or disease duration. Furthermore, the outcome of the factor analysis was in keeping with
discrete semantic and nonfluent/agrammatic syndromes but did not support a logopenic variant.
Conclusion: Taken together, the results of this prospective data-driven study suggest that although a
substantial proportion of patientswith PPAhave neither the semantic nor the nonfluent variants, they
do not necessarily conform to a discrete logopenic variant. Neurology® 2012;78:1670–1677
GLOSSARY
lvPPA  logopenic variant of primary progressive aphasia; nfvPPA  nonfluent/agrammatic variant of primary progressive
aphasia; PPA primary progressive aphasia; svPPA semantic variant of primary progressive aphasia.
Primary progressive aphasia (PPA) is a collective term for a group of clinically and pathologi-
cally heterogeneous disorders in which a neurodegenerative disease presents with language
impairment as the most salient feature.1 The current clinical formulation posits 3 variants:
semantic variant (svPPA, also known as semantic dementia), nonfluent/agrammatic variant
(nfvPPA), and logopenic variant (lvPPA).2–4 Recently, diagnostic recommendations (table 1)
have been proposed to enable identification of these 3 most commonly reported clinical pre-
sentations of PPA.5 It remains unclear, however, whether there are only 3 definable syndromes
or indeed whether all 3 of these proposed categories are sufficiently discrete and consistent to
justify them being delineated as specific syndromes.
A particular advance with these proposed recommendations was the stipulation of specific
types of tests to assess certain language features. Many of the recommendations, however, still
rely on evaluating connected speech. Despite publication of a few formal analyses,6,7 connected
speech is typically not quantified and, hence, at risk of inconsistent evaluation or bias. The
Cambridge Longitudinal Study of PPA was established for prospective evaluation of the phe-
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nomenology of PPA, using a detailed neuro-
psychological battery and formal analysis of
connected speech. In this study, 46 consecu-
tively recruited patients were tested to exam-
ine the extent to which patients would
conform to the proposed tripartite system. In
addition, a purely data-driven analysis was
undertaken to identify the elements of lin-
guistic impairment that cluster together, thus
using empirical evidence to test for the exis-
tence of discrete syndromic variants.
METHODS Participants. A total of 46 patients with a clin-
ical diagnosis of PPA were prospectively recruited over a 2 year
period (2009–2011) from the memory clinics held at Adden-
brooke’s Hospital, University of Cambridge, UK. All patients
met the basic criteria for PPA.5 Nondegenerative pathologies
were excluded using MRI, except in 3 patients who had CT
because MRI was contraindicated. Previous experience had
shown that cognitive screening tests such as the Mini-Mental
State Examination, for which responses often require speaking,
could be misleading in assessment of functional abilities in pa-
tients with prominent language problems.8,9 We designed an
informant-filled questionnaire on activities of daily living to as-
sess patients’ ability to cope with language-independent day-to-
day activities. In addition, prospective participants were
excluded if 1) English was not their first language (excluded 1
patient) or 2) their language was so impaired that they could not
provide speech samples of the length and quality required for
meaningful analysis (excluded 1 patient). Spouses/partners of pa-
tients were recruited as control subjects to be matched for gen-
eral demographic factors, especially age and education. All were
free of cognitive symptoms and neurologic or psychiatric ill-
nesses and performed normally on Addenbrooke’s Cognitive Ex-
aminationRevised.10
Standard protocol approvals, registrations, and patient
consents. Written informed consent was obtained from the
participants and, where appropriate, their next of kin. The study
was approved by the regional ethics committee.
Neuropsychological battery. All subjects with PPA and con-
trol participants performed a similar set of general neuropsychologi-
cal tests (table 2) and an extensive battery of language-specific tests
that, along with the outcome of their connected speech analysis,
were explicitly chosen to evaluate all consensus-proposed language
markers. Connected speech was elicited in 2 ways: 1) by description
of the picture (a busy domestic scene) from the Dutch version of the
Comprehensive Aphasia Test11 and 2) by semistructured interviews.
To provide an objective measure of the patients’ performance rela-
tive to that of healthy participants and to binarize the individual test
scores to normal or abnormal, which was required for the first part
of the analyses, standard scores were calculated. To examine the
degree to which the patients could be classified using the recently
proposed recommendations, their standard scores were used to
assess the presence or absence of the diagnostic features for each
of the 3 proposed variants. Inspired by criteria for minimal cog-
nitive impairment,12 a threshold of 1.5 SDs worse than the con-
trol participants’ mean was set as the boundary of normal. Data
were also analyzed using a 95% confidence interval (1.96 SDs)
to see whether this stricter threshold would be more specific in
assigning patients to syndromic groups. Raw scores were used for
principal factor analysis.
Based on the consensus recommendations, the following lan-
guage features were assessed: agrammatism in language produc-
tion; motor speech impairment; comprehension of syntactically
complex structures; basic syntactic production skills; word and
sentence repetition; confrontation naming; single word compre-
hension; object knowledge; surface dyslexia; and frequency of
phonologic errors in connected speech. Methodologic details for
the assessment of these language markers are presented in appen-
dix e-1 on the Neurology® Web site at www.neurology.org.
Statistical considerations. Predictive Analytics SoftWare
(PASW) version 18 was used for statistical analysis of the data. z
scores were calculated using the transform function in PASW.One-
way analysis of variance or its nonparametric equivalent, the
Kruskal-Wallis test, was used to compare the demographic and gen-
eral neuropsychological markers in different groups of patients and
control participants. A 2-tailed p value of 0.05 was considered signif-
icant. We also undertook principal factor analysis with orthogonal
varimax rotation on the 14 speech features listed in table 3 to iden-
tify the clustering pattern of individual measures. Factors with
eigenvalues over the Keiser criterion of 1 were retained.13
Table 1 Proposed recommendations for clinical diagnosis of PPA variants
nfvPPA: At least one core and
two-thirds of other features
svPPA: Both core and
three-fourths of other
features
lvPPA: Both core and
three-fourths of other
features
Core features Agrammatism in language
production
Impaired confrontation naming Impaired single word retrieval
in speech and naming
Effortful halting speech with
inconsistent speech sound errors
and distortions
Impaired single-word
comprehension
Impaired repetition of
sentences and phrases
Other diagnostic
features
Impaired comprehension of
syntactically complex sentences
Impaired object knowledge Phonologic errors in speech
and naming
Spared single word comprehension Surface dyslexia or dysgraphia Spared single word
comprehension and object
knowledge
Spared object knowledge Spared repetition Spared motor speech
Spared speech production Absence of frank agrammatism
Abbreviations: lvPPA  logopenic variant of primary progressive aphasia; nfvPPA  nonfluent/agrammatic variant of pri-
mary progressive aphasia; svPPA semantic variant of primary progressive aphasia.
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RESULTS Assessment of the proposed recommendations.
Every patient was assessed against the diagnostic rec-
ommendations for each of the 3 proposed variants.
With a z score threshold of 1.5, the score for none of
the patients was too mild to meet the minimum diag-
nostic criteria for one of the syndromic variants. The
frequencies of the syndromic variants are summa-
rized in table 2 along with their demographic and
general neuropsychological features.
Of the patients, 27 (59%) fitted 1 of the 3 catego-
ries, but 19 patients (41%) either fulfilled the diag-
nostic criteria for more than one variant or were too
impaired to fulfill the criteria for any variant (see ta-
ble e-1 for an example for one patient). These latter
19 patients were labeled mixed. Repeating this proce-
dure using the more stringent threshold of 1.96
SDs from the control mean led to a change in syn-
dromic classification for only one patient, from non-
fluent/agrammatic to mild/impaired on a single
measure but did not affect the mixed group member-
ship. Table 4 provides the neuropsychological and
speech data for every patient in the mixed group.
There was no statistically significant difference be-
tween the 4 patient groups (svPPA, nfvPPA, lvPPA,
Table 2 Frequency of syndromic variants and comparison of demographic and general
neuropsychological markers
nfvPPA svPPA lvPPA Mixed PPA Control
Omnibus
significance:
p (< 0.05)
No. (%) 12 (26.1) 13 (28.3) 2 (4.3) 19 (41.3) 30
Demographic
markers,
mean (range)
Age at test, y 68 (5377) 68 (61–79) 71 (68–74) 70 (60–83) 67.5 (51–80) NS
Disease duration,
y
3.5 (2–5) 4.4 (2.5–7) 2 (1.5–2.5) 3.9 (2–7) NA NS
Education, y 13 (10–20) 14 (10–19) 11 (9–13) 11 (9–16) 12.8 (10–20) NS
ADL-Q 0.73 (0–4) 1 (0–5) 0.5 (0–1) 1.3 (0–6) NA NS
General
neuropsychological
measures,
mean (range)
MMSE (30)a 24.6 (15–28)*** 23 (18–27)*** 25.5 (25–26)** 17.9 (10–28)***,b,c,d 29.2 (28–30)  0.001
ACE-R (100) 74.1 (44–89)*** 52 (36–87)***,e 72.0 (68–76)*** 46.5 (28–69)***,b,f,g 94.4 (88–99)  0.001
Forward digit
span (8)
4.5 (3–7)***,c 6.3 (4–8) 5.1 (4–6)*,f 4.4 (3–8)***,h 6.7 (5–8)  0.001
Backward digit
span (7)
3.7 (0–4)*** 4.2 (3–7) 4.0 (3–5)* 3.0 (0–6)***,c 5.1 (3–8)  0.001
Letter fluency,
words/min
5.3 (1–11)*** 6.0 (1–11)*** 6.5 (6–7)** 4.8 (1–11)*** 14.4 (4–21)  0.001
VOSP (10)i 8.2 (4–10)*,f 9.8 (9–10) 7.5 (5–10)* 6.6 (2–10)**,f 9.3 (8–10)  0.001
Rey figure
copy (36)
26.5 (2.5–36)***,f 33 (30–36) 20.5 (19–22)***,c 21.1 (0.5–35)***,h 34.6 (29–36)  0.001
Rey figure
recall (36)
10.7 (0–23)** 10 (0–25)* 5.5 (2–9)** 7.4 (0–21)*** 18.2 (0–29)  0.001
Trails-A (time), si 104.5 (47–394)***,f 49.2 (21–98) 93 (69–117)** 106.6 (48–445)***,f 37.6 (22–62)  0.001
Abbreviations: ACE-R  Addenbrooke’s Cognitive ExaminationRevised; ADL-Q  activities of daily living questionnaire;
lvPPA  logopenic variant of PPA; MMSE  Mini-Mental State Examination; NA  not applicable; nfvPPA  nonfluent/
agrammatic variant of PPA; NS nonsignificant; svPPA semantic variant of PPA; VOSP Visual Object and Perception
Battery (cube analysis).
* p 0.05 compared with the control population.
** p 0.01 compared with the control population.
*** p 0.001 compared with the control population.
a Numbers in parentheses indicate the maximum score for each test.
b p 0.001 compared with nfvPPA.
c p 0.01 compared with svPPA.
d p 0.001 compared with lvPPA.
e p 0.01 compared with nfvPPA.
f p 0.05 compared with svPPA.
g p 0.01 compared with lvPPA.
h p 0.001 compared with svPPA.
i Nonparametric test.
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and mixed PPA) and control participants in terms of
their demographic markers.
Principal factor analysis. The Keiser-Myer-Olkin mea-
sure verified the sampling adequacy for the analysis
(Keiser-Myer-Olkin  0.68, significance  0.001),
and the rotation converged in 6 iterations. The corre-
lation matrix confirmed satisfactory correlation coef-
ficients for all but the grammatical error score in
connected speech, which was not significantly corre-
lated with any of the other markers. Four factors with
eigenvalues more than 1 accounted for 64% of the
variance in the data. Examination of the Scree plot
(figure) revealed a large step down in eigenvalues
from factor 2 to factor 3. The first 2 factors ac-
counted for 42% of the variance. Table 3 shows
thresholded factor loadings of individual markers in
the factor solution (for an unthresholded version of
the table, see table e-2). Scrutiny of the rotated factor
matrix indicated that factor 1 clustered semantic
measures, factor 2 clustered measures of grammatical
competence, sentence repetition, apraxia of speech
and, with a weaker factor loading, mean length of
utterance, and factor 3 clustered a number of connected
speech markers. The fourth factor comprised only one
measure (phonologic errors).
DISCUSSION Publication of the recommendations
for classification of PPA has been a necessary first step
toward development of an empirical and unbiased cate-
gorization of the patients to clinically meaningful
groups. Application of the recommendations to pro-
spective cohorts such as this one provides an opportu-
nity for evolution of these recommendations.
By applying the proposed measures for delineat-
ing the syndromic variants of PPA to this consecu-
tively recruited cohort of 46 cases, 26.1% fulfilled
the criteria for nfvPPA and 28.3% for svPPA but
only 4.3% for lvPPA. A substantial 41.3% could
only be classified as mixed PPA in that their deficits
either extended beyond a single syndromic variant
domain (i.e., they violated the stipulation that for a
given syndromic variant a certain feature had to be
spared) or they met the criteria for more than one
variant. The possibility that this large group of mixed
cases might be attributable to a longer duration of
disease was not supported by the demographic data:
the mixed group had disease duration similar to that
of the other groups. The patients with mixed PPA
fared worse on general neuropsychological measures
at a group level, but this observation should be inter-
preted with caution. Because their aphasia was also
more diffuse, it may be that it has a more pervasive
effect on general cognition as has been noted previ-
ously.8,14 It is important to highlight the possibility
that performance on general cognitive measures was
not systematically worse in all patients with mixed
aphasia. Finally, it is worth noting that, from a
pathologic point of view, such performance is not in
itself evidence for a different pathologic grouping: in
a previous study, nonlinguistic measures were incon-
sistently affected across pathologic substrates for
PPA.15
Of note, the authors of the recent recommenda-
tions speculated that there may be instances in which
language impairment is so mild that the patient fails
to meet any criteria (i.e., by only being impaired on a
single measure)5,16; in this prospective sample, no pa-
tients fell into this category with a cutoff of 1.5 SDs
and only one patient at a threshold of 1.96.
One could argue that strict application of cutoff
scores to define the impairments that were set out in
the consensus article might be too rigid to recognize
the nuances of the proposed syndromic categories. It
is therefore notable that principle axis factoring, in-
volving no prior assumptions as to the existence of
predetermined syndromic variants, yielded a pattern
identical to the application of the consensus recom-
mendations: 2 clear syndromes and a residual mis-
cellany. The first factor clustered single word
comprehension, nonverbal associative knowledge,
picture naming, and irregular word reading. All of
Table 3 Thresholded factor loadings (>0.4) of
individual markers in the
factor solution
Factor
1 2 3 4
Point (subsection of
repeat and
point test)
0.911
Camel & Cactus
Test
0.844
64-itemNaming 0.926
Irregular word
reading
0.762
SECT (orally
presented)
0.839
MAST (active
sentences)
0.517
Sentence repetition 0.872
Apraxia of speech 0.710
Complex unit
frequency
0.773
Mean unit length 0.435 0.623
Speech rate 0.634
Hesitation markers 0.450
Phonologic errors 0.732
Grammatical errors
Abbreviations: MASTmake a sentence test; SECT sen-
tence comprehension test.
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these variables are classically associated with the syn-
drome of semantic dementia, indicating that a se-
mantic variant of PPA is readily identifiable. The
second factor, which was only slightly less significant
than the semantic factor, clustered grammatical com-
prehension, sentence repetition, apraxia of speech,
grammatical production, and mean length of utter-
ance. This factor, therefore, appears to correspond to
nfvPPA. Note, however, that impaired sentence rep-
etition aligned with this factor, whereas it has been
proposed to be a cardinal feature of lvPPA.
A binary rating of apraxia of speech was included
in the analysis because it was listed as one of the key
features in the recent classification article.5 It should
be noted, however, that the definition of apraxia of
speech remains a thorny issue because, at present,
quantifiable measures for this feature are lacking. In
this study, apraxia of speech was judged by 2 raters,
blind to neuropsychological and clinical informa-
tion, listening for “effortful halting speech with in-
consistent speech sound errors and distortions”5 in
recordings of connected speech and long word repe-
tition. Although overall interrater agreement was
fairly high (93%), this was in large part because it was
easy to decide on the absence of apraxia of speech in
many of the patients. Making a positive diagnosis of
apraxia of speech was more challenging. To date, the
literature has largely defined apraxia of speech by
clinical opinion, often citing that the rating was
made by an expert.17–20 Without tangible criteria,
however, this approach raises the question of whether
one expert means the same thing as another. This
problem is exemplified by the lack of agreement in
how different groups have defined apraxia of
speech.21–25 Moreover, even if interrater reliability
between experts could be demonstrated, this may
not be especially useful in cognitive neurology
clinics in which such expertise will be variable.
The present results suggest that, until validated
measures are available, it might be better to aban-
don apraxia of speech as a classifying feature in
PPA, given that the principle axis factoring
strongly aligned this feature to agrammatism. Fur-
thermore, removing apraxia of speech had no im-
Table 4 Individual standard and percentage corrected scores for neuropsychological and speechmeasures in the mixed groupa
Patient
Domaina and test
Object
knowledge:
CCT,%
Single
word
comp:
Point,%
Reading:
Irregular
word
reading,%
Confrontation
naming:
64-item
naming,%
Repetition:
Sentence
repetition,%
Sentence
comp:
SECT,%
Grammar Motor speech
MAST-
Active
sentence,%
Agrammatism,
composite
z-scores
Phonologic
errors,
z-score
Hesitation
markers,
z-score
Apraxia
of
speech
1 44b 80c 40b 81c 25b 40b 67b 2.61b 3.9b 1.8b 
2 73b 60b 100 70b 50b 44b 100 2.05b 6.4b 0.5 
3 0b 20b 60b 61b 83b 0b 0b 2.32b 10.1b 1.3 
4 30b 40b 100 48b 17b 0b 0b 3.20b 10.3b 1.0 
5 62b 70b 60b 2b 67b 20b 0b 0.49 4.5b 4.9b 
6 0b 40b 60b 86c 58b 0b 0b 2.66b 18.1b 1.0 
7 90 100 100 87c 25b 32b 33b 2.29b 4.4b 1.5b 
8 78b 100 100 84c 71b 72b 0b 0.91 7.1b 4.0b 
9 58b 40b 100 72b 71b 36b 0b 2.53b 0.4 9.1b 
10 76b 80c 20b 87c 42b 24b 100 1.05 8.0b 1.8b 
11 55b 70b 100 22b 75b 52b 50b 2.40b 23.3b 4.2b 
12 19b 40b 20 58b 17b 16b 67b 2.09b 0.4 5.7b 
13 67b 60b 20 89c 8b 16b 0b 3.30b 12.4bb 1.8b 
14 86 100 80c 67b 17b 32b 17b 1.95b 0.4 1.9b 
15 55b 50b 100 25b 25b 0b 0b 2.47b 6.6b 0.5 
16 37b 50b 20 0b 92 60b 17b 2.19b 0.4 0.2 
17 36b 20b 0 3b 0b 0b 0b 1.01 10.5b 0.3 
18 28b 20b 0 27b 4b 0b 0b 1.19 11.4b 0.1 
19 62b 60b 60 81c 83b 52b 67b 2.61 0.4 1.0 
Abbreviations: CCT Camel and Cactus Test; comp comprehension; MASTMake A Sentence Test; SECT Sentence Comprehension Test.
a Chosen as indicated in the recommendation article.
b Values outside 95% of the control group mean (z-scores1.96).
c Values indicate 1.5 z-score 1.96.
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pact on the clustering of the remaining markers in
the factor matrix (table e-3).
After the semantic and agrammatic factors, there
was a marked step down in significance for the re-
maining factors although 2 met the significance crite-
rion of an eigenvalue 1. The third axis included a
number of connected speech measures comprising
speech rate, frequency of complex grammatical struc-
tures, mean length of utterance (with a higher factor
loading compared to the second axis), and frequency
of hesitation markers. The fourth axis only included
phonologic errors. As shown in the Scree plot (fig-
ure), the factors did not suggest evidence for a third
discrete syndrome that stood out from the group.
Furthermore, consistent with the application of clin-
ical recommendations, which identified only 2 pa-
tients as meeting the proposed criteria for lvPPA,
factors 3 and 4 did not resemble the description of
logopenic aphasia. The proposed core features of
lvPPA are impaired word retrieval (perhaps mani-
fested by increased hesitation, i.e., word-finding
pauses) and impaired sentence repetition, but these 2
features did not cluster together, with hesitations lo-
cated in the third axis, whereas impaired sentence
repetition aligned, with markers of agrammatism/
apraxia of speech, to the second factor. It is also note-
worthy that, although the criteria for lvPPA merely
specify impaired sentence repetition with no further
qualifications, we did not penalize apraxic errors in
our sentence repetition task and the scoring criteria
were weighted toward detection of impairments in
maintaining the structure and content of the sen-
tence as opposed to word-level errors (see appendix
e-1). Moreover, the authors of the recommendations
noted that single word repetition can be spared in
lvPPA, implying that the ratio of sentence to single
word repetition might be a more specific indicator.
When we replaced sentence repetition with a ratio of
sentence (of 6–8 syllables) to single 2-syllable word
repetition to see whether this might tease out a
logopenic type factor, this variable still aligned with
the nfvPPA factor (data not shown). The proposed
lvPPA criteria also stipulate phonologic errors, but
this feature appeared in the fourth axis in isolation.
Taken together, the results of this prospective
data-driven study raise questions about the existence
of lvPPA as a discrete linguistic syndrome. The re-
sults do identify 3 groups in the sense that a substan-
tial proportion of patients have neither the semantic
nor the nonfluent/agrammatic variant. One can de-
fine a group by its absence of the features of other
groups, but to call this a syndrome would not make
sense. The 3 positive features proposed in lvPPA, im-
paired word retrieval, impaired sentence repetition,
and phonologic errors, may simply be insufficiently
specific to separate this group from the other 2 syn-
dromes. This is not an unprecedented finding be-
cause a lack of specific and distinctive features in the
logopenic group has previously been documented in
the literature.26 The remaining criteria for lvPPA
were all negatives: absence of 1) impairment in word/
object comprehension, 2) apraxia of speech, and 3)
agrammatism. In other words, to some degree, im-
plicit in the recommendations themselves is the no-
tion that this syndrome is defined by the absence of
the characteristics of the other 2 syndromes.
Previous studies have reported that, of the 3 syn-
dromic variants, lvPPA is most associated with Alzhei-
mer pathology27,28 although pathologic homogeneity
cannot be viewed as evidence for a discrete clinical syn-
drome. Only 2 patients (4%) met the criteria for lvPPA
in this consecutive cohort, yet previous studies have sug-
gested that Alzheimer pathology is the underlying diag-
nosis in almost one-third of patients with PPA.29,30
Mixed PPA, in contrast, accounted for about one-third
of cases in this cohort. We speculate that unlike the 2
reasonably discrete syndromes of semantic and nonflu-
ent/agrammatic PPA, which are mainly associated with
non-Alzheimer disease pathology,31,32 the linguistically
heterogeneous features in these patients (mixed PPA)
are most likely to be those associated with Alzheimer
pathology.
Based on the present results, we propose that
there are 2 clearly definable PPA syndromes: seman-
tic and nonfluent/agrammatic. There are, in addi-
tion, a substantial number of patients with PPA who
are not accommodated in these 2 syndromes. Such
patients are heterogeneous in terms of language fea-
tures. If one adopts a priori a tripartite view of PPA,
as was recently proposed, then 3 groups will emerge,
Figure Scree plot showing the relative significance of different factors
Note the significant reduction in eigenvalue from factor 2 to factor 3.
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but in this scenario, one syndrome will be defined as
the absence of the other 2.
A caveat to the present findings is that this analy-
sis was confined to the language features of the re-
cently proposed recommendations; it is therefore at
least possible that other linguistic markers may iden-
tify presently unknown language syndromes. In ad-
dition, on a methodologic note, we acknowledge that
the number of participants in our study was relatively
small compared with the number of language mark-
ers assessed. Conversely, the strength of the factor
loadings, especially in the first 2 axes, which led to
factor saturations greater than 0.6, argues for reliabil-
ity of our findings: previous studies have suggested
that strong factor loadings make the analysis less de-
pendent upon the sample size.33 Nevertheless, we ac-
knowledge that this has been an exploratory analysis,
and further studies are required to evaluate the find-
ings of the present work.
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Editor’s Note to Authors and Readers: Levels of Evidence coming to Neurology®
Effective January 15, 2009, authors submitting Articles or Clinical/Scientific Notes to Neurology® that report on clinical
therapeutic studies must state the study type, the primary research question(s), and the classification of level of evidence assigned
to each question based on the classification scheme requirements shown below (left). While the authors will initially assign a
level of evidence, the final level will be adjudicated by an independent team prior to publication. Ultimately, these levels can be
translated into classes of recommendations for clinical care, as shown below (right). For more information, please access the
articles and the editorial on the use of classification of levels of evidence published in Neurology.1-3
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